The American Kratom Association (AKA) applauds the announcement of the FDA’s decision to withdraw its “Proposed Collection; Comment Request: Risk/Safety Considerations and Motivations for Purchase and Use of Kratom and Psychedelics Alone and in Combination with Other Substances” originally published on August 2, 2024.
"The FDA has once again shown its clear bias against any harm reduction tool that does not fit into a new drug application model," stated Mac Haddow, Senior Fellow on Public Policy with the AKA. "This is the latest embarrassing mistake driven by a few anti-kratom staff at the FDA, and it is time for Commissioner Califf to exercise direct oversight and order the Agency to reassess its biased attacks on kratom and psychedelics."
The FDA announced its swift withdrawal of the Federal Register Notice that was originally published on August 2, 2024, in a new Notice on August 9 (https://public-inspection.federalregister.gov/2024-17793.pdf). The FDA explained that it withdrew the study because "circumstances occurred necessitating changes to the scope of the study."
"The FDA’s few anti-kratom staff are repeatedly undermining the Agency’s credibility on harm reduction strategies," Haddow continued. "The National Institutes on Drug Abuse is light years ahead of the FDA in identifying harm reduction tools, like kratom and psychedelics, that make a real difference in improving the health and well-being of those struggling with pain and mental health issues, including saving the lives of many who otherwise would lose their struggles."
"It is well past the time that Commissioner Califf should convene a stakeholder meeting with leading scientists, policy experts, and consumer advocates to determine the next best steps to protect access to safely manufactured, properly labeled, and age restricted kratom products,” concluded Haddow. "Until then, the FDA remains trapped in the web of their own making that unfairly demonizes products like kratom and psychedelics that, when properly used, are helping people who struggle with addictions and mental health issues and that are saving lives."
About American Kratom Association (AKA)
The American Kratom Association (AKA), a consumer-based non-profit organization, advocates to protect the freedom of consumers to safely consume natural kratom as a part of their personal health and well-being regimen. AKA represents the nearly 20 million Americans who consume kratom safely each year. For more information, visit www.americankratom.org.
Media Contact
Mac Haddow
+1 571-294-5978
"The FDA has once again shown its clear bias against any harm reduction tool that does not fit into a new drug application model," stated Mac Haddow, Senior Fellow on Public Policy with the AKA. "This is the latest embarrassing mistake driven by a few anti-kratom staff at the FDA, and it is time for Commissioner Califf to exercise direct oversight and order the Agency to reassess its biased attacks on kratom and psychedelics."
The FDA announced its swift withdrawal of the Federal Register Notice that was originally published on August 2, 2024, in a new Notice on August 9 (https://public-inspection.federalregister.gov/2024-17793.pdf). The FDA explained that it withdrew the study because "circumstances occurred necessitating changes to the scope of the study."
"The FDA’s few anti-kratom staff are repeatedly undermining the Agency’s credibility on harm reduction strategies," Haddow continued. "The National Institutes on Drug Abuse is light years ahead of the FDA in identifying harm reduction tools, like kratom and psychedelics, that make a real difference in improving the health and well-being of those struggling with pain and mental health issues, including saving the lives of many who otherwise would lose their struggles."
"It is well past the time that Commissioner Califf should convene a stakeholder meeting with leading scientists, policy experts, and consumer advocates to determine the next best steps to protect access to safely manufactured, properly labeled, and age restricted kratom products,” concluded Haddow. "Until then, the FDA remains trapped in the web of their own making that unfairly demonizes products like kratom and psychedelics that, when properly used, are helping people who struggle with addictions and mental health issues and that are saving lives."
About American Kratom Association (AKA)
The American Kratom Association (AKA), a consumer-based non-profit organization, advocates to protect the freedom of consumers to safely consume natural kratom as a part of their personal health and well-being regimen. AKA represents the nearly 20 million Americans who consume kratom safely each year. For more information, visit www.americankratom.org.
Media Contact
Mac Haddow
+1 571-294-5978
